About the journal
Precision Medication is an open-access journal published by KeAi Communications Co., Ltd. in China, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- KeAi Communications Co., Ltd.
- ISSN
- 2950-5232
- Country
- China
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 USD
- Articles in DOAJ
- 51
- Declared review time
- 14 weeks
- Declared peer-review model
- double_blind
- Official website
- https://www.keaipublishing.com/en/journals/precision-medication/
Index listings
- DOAJ · 2025-11-16
- Indexing
- DOAJ
- APC
- 1,000 USD
- Declared review time (DOAJ)
- 14 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
51
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
48
Last recorded publication year
2025
h-index
3
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2025-11-16
- Added to DOAJ
- 2025-11-16
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 19%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Precision medication
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Pneumonia and Respiratory Infections
- Pharmaceutical Practices and Patient Outcomes
- Bioinformatics and Genomic Networks
- Pharmaceutical Practices and Patient Outcomes
- Diabetes Treatment and Management
- Nosocomial Infections in ICU
Show all subjects (50)
- Antibiotics Pharmacokinetics and Efficacy
- Bioinformatics and Genomic Networks
- Antibiotics Pharmacokinetics and Efficacy
- Cardiovascular Function and Risk Factors
- Ferroptosis and cancer prognosis
- Metabolomics and Mass Spectrometry Studies
- Pharmacogenetics and Drug Metabolism
- Metabolomics and Mass Spectrometry Studies
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pharmacogenetics and Drug Metabolism
- Cardiovascular Function and Risk Factors
- Ferroptosis and cancer prognosis
- Liver Disease Diagnosis and Treatment
- Heart Failure Treatment and Management
- Antifungal resistance and susceptibility
- Traditional Chinese Medicine Analysis
- Drug-Induced Adverse Reactions
- Fungal Infections and Studies
- Tryptophan and brain disorders
- Metabolism, Diabetes, and Cancer
- Drug-Induced Hepatotoxicity and Protection
- Cancer therapeutics and mechanisms
- Extracellular vesicles in disease
- Cancer Genomics and Diagnostics
- Traditional Chinese Medicine Studies
- Traditional Chinese Medicine Analysis
- Lipoproteins and Cardiovascular Health
- Diabetes Treatment and Management
- Fungal Infections and Studies
- Drug-Induced Adverse Reactions
- Antifungal resistance and susceptibility
- Heart Failure Treatment and Management
- Liver Disease Diagnosis and Treatment
- Tryptophan and brain disorders
- Drug-Induced Hepatotoxicity and Protection
- Pharmacovigilance and Adverse Drug Reactions
- Cancer therapeutics and mechanisms
- Metabolism, Diabetes, and Cancer
- Cancer Genomics and Diagnostics
- Extracellular vesicles in disease
- Lipoproteins and Cardiovascular Health
Keywords (DOAJ)
- precision therapeutics
- personalized medicine
- pharmaco-metabonomics
- pharmacogenomics
- clinical pharmacology
- drug development
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ